Compulsory licences: necessity or threat?

In an opinion article for Chemistry World, Darren Smyth joins five other international experts on the subject in giving his view on whether compulsory licences for patent-protected drugs are a necessary measure, or a threat to innovation.

Subscribe to The Patent Strategist newsletter

Thank you for your interest.

Subscribe to The Patent Strategist newsletter

Get expert insights and the top patent stories delivered straight to your inbox.